Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

geko T-3 Neuromuscular Stimulator

K-Number: K181059 · 2018-05-23

Decision Date2018-05-23
Product CodeIPF
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

geko T-3 Neuromuscular Stimulator is the device name listed in this FDA 510(k) record. The listed applicant is Firstkind Limited. It received FDA 510(k) clearance on 2018-05-23 under 510(k) number K181059. The device is classified under product code IPF. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the geko T-3 Neuromuscular Stimulator?

geko T-3 Neuromuscular Stimulator is a medical device that received FDA 510(k) clearance on 2018-05-23. The listed applicant is Firstkind Limited. The 510(k) number is K181059.

When did geko T-3 Neuromuscular Stimulator receive FDA 510(k) clearance?

geko T-3 Neuromuscular Stimulator received FDA 510(k) clearance on 2018-05-23, under 510(k) number K181059.

Who is the listed applicant for geko T-3 Neuromuscular Stimulator?

The FDA 510(k) record lists Firstkind Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for geko T-3 Neuromuscular Stimulator?

The FDA product code for geko T-3 Neuromuscular Stimulator is IPF.

Other records listing Firstkind Limited as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 9 devices →

Related Devices (Code: IPF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.